Background— The French pulmonary hypertension (PH) registry allows the survey of
epidemiological trends. Isolated cases of precapillary PH have been reported in patients who have …

Current European guidelines recommend periodic risk assessment for patients with
pulmonary arterial hypertension (PAH). The aim of our study was to determine the association …

Patients with severe pulmonary arterial hypertension (PAH) in New York Heart Association (NYHA)
functional class (FC) III/IV have a poor prognosis, despite survival benefits being …

Background Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease,
predisposing to an increased risk of infection. A complete picture of these infections is lacking. …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recently discovered
coronavirus, is responsible for COVID-19, a newly emerged disease that has become pandemic. …

Fiberoptic bronchoscopy (FOB) may worsen oxygenation and clinical status in severely
hypoxemic patients. We conducted a prospective, randomized double-blind trial to compare the …

Rationale: The relationship between the initial treatment strategy and survival in pulmonary
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …

Treatment for pulmonary arterial hypertension (PAH) has been underpinned by single-agent
therapy to which concomitant drugs are added sequentially when pre-defined treatment …

Background The use of cyclophosphamide in patients with acute exacerbation of idiopathic
pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and …

Cases of paradoxical worsening of opportunistic infections shortly after the beginning of
highly active antiretroviral therapy (HAART) prompted questions on the optimal timing of …